Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP5399.RAwN2oyDHfdyMv3gLv9Kbh3sMCVXCEHqy4Sv0e4LjxcvY#assertion> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- assertion wasGeneratedBy ECO_0000203 provenance.
- assertion wasDerivedFrom BEFREE provenance.
- assertion SIO_000772 18048643 provenance.
- assertion evidence source_evidence_literature provenance.
- assertion description "[Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is active in patients with imatinib-resistant or -intolerant accelerated-phase chronic myelogenous leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.